Taking a detailed history of substance use is particularly
important in aggressive patients with schizophrenia.
Information that emerges in a patient’s history is
frequently useful and sometimes intriguing. For example,
aggressive schizophrenia patients reporting a history of
improved subjective well-being with prior cannabis use
can experience amelioration of aggressive behavior
with dronabinol, a schedule III controlled substancethat contains delta-9-tetrahydrocannabinol, a major active
ingredient found in marijuana